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2-Styrylchromones (2-SC) are chromone derivatives, vinylogues of 
flavones (2-phenylchromones). Some compounds from this group have 
demonstrated to possess biological effects with potential therapeutic 
applications such as antiallergic, antitumor, antiviral, antioxidant and 
anti-inflammatory activities. This last point deserves our special interest 
because we believe that 2-SC backbone is endowed with anti-
inflammatory potential due to its similarities with flavonoids, the class of 
flavones in particular, which have shown interesting results in this field. 
The activation of the transcription factor nuclear factor kappa B (NF-KB) 
is known to trigger a cascade of signalling events, namely the expression 
of many cytokines, enzymes, chemokines, and adhesion molecules, 
some of which being potential key targets for intervention in the 
treatment of inflammatory conditions. Indeed, accepted anti-
inflammatory therapeutic options such as glucocorticoids, cyclosporine, 
tacrolimus, non-steroidal anti-inflammatory drugs (NSAIDs), and 
sulfasalazine were shown to modulate the NF-KB pathway by several 
mechanisms. 
Thus, the aim of the present work was to study the influence of a group 
of 2-SC in the activation of the NF-KB pathway in THP-1 cells, a human 
monocytic cell line. First, we studied the ability of the compounds to 
inhibit LPS-induced NF-KB activation. Subsequently, we analysed 
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different stages of the signalling pathway in order to understand the 
mechanism by which the effective compounds acted. Finally we 
evaluated the capacity of the most potent NF-KB inhibitors to inhibit the 
production of pro-inflammatory cytokines . 
In this study, new inhibitors of the NF-KB pathway were found, being 
promising candidates for alternative anti-inflammatory drugs. 
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